1.
Changes of neuropeptide Y after intracerebral hemorragic rats and the intervention effects of recombinant activated factor Ⅶ
实验性脑出血后神经肽Y的变化及重组活化凝血因子Ⅶ的干预作用
2.
The Clinical Evaluation and Antiapoptotic Effect Study of Recombinant Activated Factor Ⅶ for Acute Intracerebral Hemorrhage;
重组活化凝血因子Ⅶ超早期治疗脑出血的临床疗效观察及其抗细胞凋亡作用的研究
3.
Study on Expression and Purification of Recombinant Human Coagulation Factor Ⅶ in Mammalian Cell Line;
重组人凝血因子Ⅶ的表达与纯化研究
4.
Expression and Identification of Recombinant Human Coagulation Factor Ⅶa in Eukaryotic Cells;
重组人凝血因子Ⅶ在真核细胞中的表达研究
5.
Application of recombinant activated factor Ⅶ and abdominal packing on damage control surgery
联合活化重组Ⅶ因子和腹腔填塞在损害控制中的应用
6.
Ectopic expression and clinical significance of tissue factor/coagulation factor Ⅶ complex in colorectal cancer
组织因子/凝血因子Ⅶ在大肠癌中的异位表达及其临床意义
7.
Active FⅦ Ectopic Synthesis in Colorectal Carcinoma and Correlation with the Cancer Metastasis;
大肠癌中活化凝血因子Ⅶ的异源性表达及其与大肠癌转移关系的研究
8.
Hemorrhagic features and the application of recombinant activated factor VⅡ in liver transplantation
肝移植出血特点及活化重组人凝血因子VⅡ在移植中的应用(英文)
9.
Genetic Research of Macaca Mulatta Coagulation Factors of Ⅶ, Ⅸ and Ⅺ;
恒河猴凝血因子Ⅶ、Ⅸ、Ⅺ的遗传分子研究
10.
Development Research on Interaction of Coagulation Factor Ⅶ and its Receptor
凝血因子Ⅶ及其受体相互作用的研究进展
11.
The Relations of Gene Polymorphisms of eNOS and FⅦ with Coronary Heart Disease in Henan Han Population;
河南汉族人群一氧化氮合酶和凝血因子Ⅶ基因多态性与冠心病相关性分析
12.
The correlation between the levels of plasma factor Ⅶ,Ⅷ and macroangiopathy in patients with type 2 diabetes
2型糖尿病患者血浆凝血因子Ⅶ、Ⅷ水平与大血管病变的相关性研究
13.
Study on serum level of sICAM-1 and FⅦ in patients with acute cerebral infarction and its clinical significance
脑梗死患者血清细胞间黏附分子-1和凝血因子Ⅶ的水平研究及临床意义
14.
Clone, expression, purification and quantitative bioassay of recombinant human platelet factor 4;
重组人血小板因子4基因的克隆、表达、纯化和活性初步鉴定
15.
Study on the Determination of Tissue Factor Activity with Whole Blood Clotting Time
利用全血凝固时间测定组织因子活性的研究
16.
Cloning, Expression, Purification and Bioassay of Recombinant Human Platelet Factor 4;
重组人血小板因子4的克隆、表达、纯化和活性鉴定
17.
Recombinant Factor Ⅷ for Treatment of Patients with Hemophilia A in China
重组人凝血因子Ⅷ在中国人血友病A患者中的安全性和有效性探讨
18.
Effects of dalteparin and unfractionated heparin on plasma anti-Xa activity and activated clotting time during elective percutaneous coronary intervention or coronary angiography
达肝素与普通肝素对血浆抗凝血因子Ⅹa活性及活化凝血时间影响的对比研究